Related references
Note: Only part of the references are listed.Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders
M. A. Schiele et al.
GENES BRAIN AND BEHAVIOR (2018)
GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder
J. Deckert et al.
MOLECULAR PSYCHIATRY (2017)
Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms
Shi Tang et al.
PEPTIDES (2017)
Orexin modulates behavioral fear expression through the locus coeruleus
Shingo Soya et al.
NATURE COMMUNICATIONS (2017)
Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility
Laura A. Grafe et al.
BIOLOGICAL PSYCHIATRY (2017)
Novel developments in genetic and epigenetic mechanisms of anxiety
Michael G. Gottschalk et al.
CURRENT OPINION IN PSYCHIATRY (2016)
Panic disorder with agoraphobia from a behavioral neuroscience perspective: Applying the research principles formulated by the Research Domain Criteria (RDoC) initiative
Alfons O. Hamm et al.
PSYCHOPHYSIOLOGY (2016)
Personalized therapies in psychiatry: promises, pitfalls and perspectives
Katharina Domschke et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia
Eliora Porter et al.
CLINICAL PSYCHOLOGY REVIEW (2015)
Orexin/hypocretin receptor signalling: a functional perspective
C. S. Leonard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Orexin/hypocretin receptor signalling cascades
J. P. Kukkonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Is HCRTR2 a Genetic Risk Factor for Alzheimer's Disease?
Salvatore Gallone et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2014)
Arousal and the attentional network in panic disorder
Maximilian J. Geiger et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Brainstem response to hypercapnia: A symptom provocation study into the pathophysiology of panic disorder
Liesbet Goossens et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy
A. Reif et al.
MOLECULAR PSYCHIATRY (2014)
The role of orexin in motivated behaviours
Takeshi Sakurai
NATURE REVIEWS NEUROSCIENCE (2014)
The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
Africa Flores et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala
David H. Arendt et al.
PSYCHONEUROENDOCRINOLOGY (2014)
The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: Associations to symptom severity, treatment course, and outcome
Sylvia Helbig-Lang et al.
JOURNAL OF ANXIETY DISORDERS (2014)
Changes in Automatic Threat Processing Precede and Predict Clinical Changes with Exposure-Based Cognitive-Behavior Therapy for Panic Disorder
Andrea Reinecke et al.
BIOLOGICAL PSYCHIATRY (2013)
Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder
Thomas Dresler et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Orexin Receptor-1 in the Locus Coeruleus Plays an Important Role in Cue-Dependent Fear Memory Consolidation
Shingo Soya et al.
JOURNAL OF NEUROSCIENCE (2013)
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
Robert M. Sears et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations
Andreas Reif et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2012)
The Attention System of the Human Brain: 20 Years After
Steven E. Petersen et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
Dynamics of Defensive Reactivity in Patients with Panic Disorder and Agoraphobia: Implications for the Etiology of Panic Disorder
Jan Richter et al.
BIOLOGICAL PSYCHIATRY (2012)
Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
Philip L. Johnson et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
Philip L. Johnson et al.
PHYSIOLOGY & BEHAVIOR (2012)
Orexin, stress, and anxiety/panic states
Philip L. Johnson et al.
OREXIN/HYPOCRETIN SYSTEM (2012)
Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene
Kristina Annerbrink et al.
PSYCHIATRIC GENETICS (2011)
Neural correlates of trait anxiety in fear extinction
C. Sehlmeyer et al.
PSYCHOLOGICAL MEDICINE (2011)
Psychological Treatment for Panic Disorder With Agoraphobia: A Randomized Controlled Trial to Examine the Role of Therapist-Guided Exposure In Situ in CBT
Andrew T. Gloster et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2011)
A key role for orexin in panic anxiety
Philip L. Johnson et al.
NATURE MEDICINE (2010)
Catastrophic Misinterpretations as a Predictor of Symptom Change During Treatment for Panic Disorder
Bethany A. Teachman et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2010)
Interoceptive sensitivity in anxiety and anxiety disorders: An overview and integration of neurobiological findings
Katharina Domschke et al.
CLINICAL PSYCHOLOGY REVIEW (2010)
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia
A. T. Gloster et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Meta-analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity
Katharina Domschke et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference
Daniel E. Ho et al.
POLITICAL ANALYSIS (2007)
The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia
Yuko Fukunaka et al.
NEUROMOLECULAR MEDICINE (2007)
Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects
RM Salomon et al.
BIOLOGICAL PSYCHIATRY (2003)
Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus
O Jöhren et al.
PEPTIDES (2002)
Differential expression of orexin receptors 1 and 2 in the rat brain
JN Marcus et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
Share Paper
